Fingers point at Baxter over Croatian dialysis deaths
This article was originally published in Clinica
Executive Summary
Baxter Healthcare has found itself immersed again in a second major haemodialysis scare in as many months, with the death last week of 23 renal patients undergoing treatment in several Croatian hospitals. No conclusive proof of cause had been established by October 15, but use of dialysers manufactured by the US multinational appeared to be the common link in the deaths.